A nursing student asks the nurse why more is not known about the teratogenic effects of maternal medication ingestion during pregnancy. Which response by the nurse is correct?
“Clinical trials to assess this risk would put the fetus at risk.”
“The relatively new FDA study will allow testing of medications during pregnancy in the future.”
“Most women are reluctant to admit taking medications while they are pregnant.”
“It is safer to recommend that pregnant women avoid medications while pregnant.”
The Correct Answer is A
Choice A Reason:
Clinical trials to assess the teratogenic effects of medications during pregnancy are ethically challenging because they would involve exposing pregnant women and their fetuses to potential risks. The primary concern is the safety of the fetus, as many drugs can cross the placenta and potentially cause harm. Therefore, most of the data on teratogenic effects come from observational studies, case reports, and animal studies rather than controlled clinical trials.
Choice B Reason:
While the FDA has initiatives to improve the safety of medications during pregnancy, it is not accurate to say that a new study will allow testing of medications during pregnancy in the future. The ethical concerns surrounding the exposure of pregnant women to potential teratogens remain a significant barrier. Current efforts focus on improving post-marketing surveillance and encouraging the reporting of adverse effects to gather more data.
Choice C Reason:
Although some women may be reluctant to admit taking medications during pregnancy, this is not the primary reason for the lack of data on teratogenic effects. The main issue is the ethical and practical challenges of conducting clinical trials in pregnant women. Reluctance to report medication use can contribute to underreporting, but it is not the central factor.
Choice D Reason:
Recommending that pregnant women avoid medications is a general precaution, but it does not address the reason why more is not known about teratogenic effects. The avoidance of medications is advised to minimize potential risks, but the lack of data is primarily due to the ethical constraints of conducting clinical trials in this population.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A Reason:
Respiratory alkalosis occurs when a person breathes rapidly (hyperventilates), causing a decrease in carbon dioxide (CO2) levels in the blood. This reduction in CO2 leads to an increase in blood pH, resulting in alkalosis. Hyperventilation can be triggered by anxiety, fever, or other conditions that increase respiratory rate.
Choice B Reason:
Metabolic alkalosis is caused by an increase in bicarbonate (HCO3-) or a loss of hydrogen ions (H+), often due to vomiting, diuretic use, or excessive bicarbonate intake. It is not directly related to hyperventilation, which primarily affects CO2 levels rather than bicarbonate levels.
Choice C Reason:
Metabolic acidosis occurs when there is an excess of acid in the body or a loss of bicarbonate, often due to conditions like diabetic ketoacidosis, renal failure, or severe diarrhea. Hyperventilation does not cause metabolic acidosis; instead, it can be a compensatory response to metabolic acidosis to help lower CO2 levels and increase pH.
Choice D Reason:
Respiratory acidosis is caused by hypoventilation, where there is inadequate removal of CO2 from the body, leading to an increase in CO2 levels and a decrease in blood pH. This condition is the opposite of what occurs during hyperventilation, making this choice incorrect.
Correct Answer is B
Explanation
Choice A: Convert Amino Acid to Glucose
The process of converting amino acids to glucose is known as gluconeogenesis. This metabolic pathway allows the body to produce glucose from non-carbohydrate sources, such as amino acids, during periods of fasting or intense exercise. While this process is crucial for maintaining blood glucose levels, it is not the definition of glycogenolysis.
Choice B: Break Down Glycogen to Glucose
Glycogenolysis is the biochemical process of breaking down glycogen into glucose. Glycogen, a stored form of glucose in the liver and muscle cells, is broken down to provide immediate energy and to maintain blood glucose levels during fasting or intense physical activity. This process is regulated by hormones such as glucagon and epinephrine, which activate enzymes that catalyze the breakdown of glycogen into glucose-1-phosphate and then into glucose-6-phosphate3. The glucose-6-phosphate can then be used in glycolysis to produce energy or released into the bloodstream to maintain blood glucose levels.
Choice C: Convert Glucose to Amino Acid
The conversion of glucose to amino acids is not a typical metabolic pathway. Instead, glucose is primarily used for energy production through glycolysis and the citric acid cycle. Amino acids are synthesized from intermediates of these pathways and other metabolic processes, but glucose itself is not directly converted into amino acids.
Choice D: Convert Fat to Amino Acid
The conversion of fats to amino acids is not a standard metabolic process. Fats are broken down into fatty acids and glycerol through lipolysis. Fatty acids can be further oxidized to produce energy, while glycerol can enter gluconeogenesis to produce glucose. Amino acids, on the other hand, are derived from dietary proteins or synthesized from other amino acids and metabolic intermediates.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.